top of page
What we do
TheraLyze.ai revolutionizes pharmacovigilance by automating omni-channel case intake, eliminating manual data entry, and generating regulator-ready E2B(R3) files — cutting processing time from hours to minutes while reducing costs and ensuring global compliance.
Use Case
CROs and pharma companies rely on TheraLyze.ai to:
-
📥 Automate omni-channel case intake
-
🔍 AI extracts data from any source format
-
📑 Generate E2B(R3)-compliant files instantly
-
🔗 Integrate seamlessly with existing safety databases
👉 Outcome: Faster, cheaper, compliant case processing.
How it works
Users upload raw safety data in any language to TheraLyze.ai, which processes the files using AI, extracts relevant information, and generates structured E2B R3 files ready for submission to any PV Database for regulatory authorities.
Founder, CEO
Sunil Kulkarni, founder & CEO of TheraLyze.ai, leverages deep expertise in technology and life sciences. Formerly a leader at Veeva Systems, he specializes in AI, machine learning, and scalable tools & solutions to save time, streamline workflows, boost quality, and ensure compliance.
(Head of Global Pharmacovigilance, Worwag Pharma)
bottom of page